TITLE

Repeated injection of PEGylated solid lipid nanoparticles induces accelerated blood clearance in mice and beagles

AUTHOR(S)
Yongxue Zhao; Long Wang; Mina Yan; Yanling Ma; Guangxi Zang; Zhennan She; Yihui Deng
PUB. DATE
January 2012
SOURCE
International Journal of Nanomedicine;2012, Vol. 7, p2891
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
82509022

 

Related Articles

  • Accelerated Blood Clearance Was Not Induced for a Gadolinium-Containing PEG-poly(L-lysine)-Based Polymeric Micelle in Mice. Huili Ma; Shiraishi, Kouichi; Minowa, Takuya; Kawano, Kumi; Yokoyama, Masayuki; Hattori, Yoshiyuki; Maitani, Yoshie // Pharmaceutical Research;Feb2010, Vol. 27 Issue 2, p296 

    Accelerated blood clearance (ABC) is induced by repeated injections of PEGylated liposomes. In this study, the ABC was investigated for a gadolinium-containing PEG-poly(L-lysine)-based polymeric micelle (Gd-micelle) and PEGylated liposome (Gd-liposome) in mice. Effects of the first injection of...

  • Accelerated Blood Clearance of PEGylated PLGA Nanoparticles Following Repeated Injections: Effects of Polymer Dose, PEG Coating, and Encapsulated Anticancer Drug. Saadati, Roonak; Dadashzadeh, Simin; Abbasian, Zahra; Soleimanjahi, Hoorieh // Pharmaceutical Research;Apr2013, Vol. 30 Issue 4, p985 

    Purpose: To investigate accelerated blood clearance (ABC) induction upon repeated injections of PLGA-PEG nanoparticles as a commonly used polymeric drug carrier. Methods: Etoposide-loaded PLGA-PEG NPs were developed and administered as the test dose to rats pre-injected with various NP...

  • Enhanced Retention of Celecoxib-Loaded Solid Lipid Nanoparticles after Intra-Articular Administration. Thakkar, Hetal; Sharma, Rakesh Kumar; Murthy, R. S. R. // Drugs in R&D;2007, Vol. 8 Issue 5, p275 

    Objective: The objective of this study was to determine whether the retention of celecoxib in inflamed articular joints of arthritic rats could be enhanced by incorporation of the drug into solid lipid nanoparticles. Methods: Celecoxib-loaded solid lipid nanoparticles (SLN) were prepared by...

  • Nanoparticle clearance is governed by Th1/Th2 immunity and strain background. Jones, Stephen W.; Roberts, Reid A.; Robbins, Gregory R.; Perry, Jillian L.; Kai, Marc P.; Kai Chen; Tao Bo; Napier, Mary E.; Ting, Jenny P. Y.; DeSimone, Joseph M.; Bear, James E. // Journal of Clinical Investigation;Jul2013, Vol. 123 Issue 7, p3061 

    Extended circulation of nanoparticles in blood is essential for most clinical applications. Nanoparticles are rapidly cleared by cells of the mononuclear phagocyte system (MPS). Approaches such as grafting polyethylene glycol onto particles (PEGylation) extend circulation times; however, these...

  • Induction of intratumoral tumor necrosis factor by a synthetic lipid A analog, ONO-4007, with less tolerance in repeated administration and its implication in potent antitumor effects with low toxicity. Satoh, Motonobu; Tsurumaki, Kazusa; Kagehara, Hideaki; Yamazaki, Masatoshi // Cancer Immunology, Immunotherapy;Feb2002, Vol. 50 Issue 12, p653 

    To evaluate the anti-tumor characteristics of ONO-4007, a synthetic analog of lipid A, the authors examined its acute toxicity and anti-tumor activity in a mouse MM46 mammary tumor system in comparison with LA-15-PP, an E. coli-type synthetic lipid A and LPS. Systemic and local (tumor site)...

  • Allometric scaling of pegylated liposomal anticancer drugs. Caron, Whitney; Clewell, Harvey; Dedrick, Robert; Ramanathan, Ramesh; Davis, Whitney; Yu, Ning; Tonda, Margaret; Schellens, Jan; Beijnen, Jos; Zamboni, William // Journal of Pharmacokinetics & Pharmacodynamics;Oct2011, Vol. 38 Issue 5, p653 

    Pegylated liposomal formulations contain lipid conjugated to polyethylene glycol. The disposition of encapsulated drug is dictated by the composition of the liposome, thus altering the pharmacokinetic (PK) profile of the drug. Allometric scaling is based on a power-log relationship between body...

  • Pharmacokinetic and Anti-inflammatory Effects of Sanguinarine Solid Lipid Nanoparticles. Li, Weifeng; Li, Huani; Yao, Huan; Mu, Qingli; Zhao, Guilan; Li, Yongmei; Hu, Hua; Niu, Xiaofeng // Inflammation;Apr2014, Vol. 37 Issue 2, p632 

    The sanguinarine (SG) was studied for its pharmacokinetic and anti-inflammatory activities with prepared solid lipid nanoparticles (SLNs). The sanguinarine solid lipid nanoparticles (SG-SLNs) were prepared by film-ultrasonic dispersion method and the entrapment efficiency of SG was higher at...

  • Solid Lipid Nanoparticles.  // Cosmetics & Toiletries;Jul2008, Vol. 123 Issue 7, p91 

    The article presents abstracts on solid lipid nanoparticles which include the first generation of solid lipid nanoparticles, the advantages of solid lipid nanoparticles and nanostructured lipid carriers and the incorporation of titanium dioxide into solid lipid nanoparticles.

  • Pharmacokinetics of Pegylated Liposomal Doxorubicin: Review of Animal and Human Studies. Gabizon, Alberto; Shmeeda, Hilary; Barenholz, Yechezkel // Clinical Pharmacokinetics;Mar2003, Vol. 42 Issue 5, p419 

    Pegylated liposomal doxorubicin (doxorubicin HCl liposome injection; Doxil[sup ®] or Caelyx[sup ®]) is a liposomal formulation of doxorubicin, reducing uptake by the reticulo-endothelial system due to the attachment of polyethylene glycol polymers to a lipid anchor and stably retaining...

  • Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system. Sengupta, Shiladitya; Eavarone, David; Capila, Ishan; Ganlin Zhao; Watson, Nicki; Kiziltepe, Tanyel; Sasisekharan, Ram // Nature;7/28/2005, Vol. 436 Issue 7050, p568 

    In the continuing search for effective treatments for cancer, the emerging model is the combination of traditional chemotherapy with anti-angiogenesis agents that inhibit blood vessel growth. However, the implementation of this strategy has faced two major obstacles. First, the long-term...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics